Texas Diabetes & Endocrinology

The trials here

What the 14 trials at this site are about, from their registry records.

Conditions

• Type 1 diabetes6 trials
• Type 2 diabetes6 trials
• Obesity3 trials
• Alzheimer disease2 trials
• High blood pressure1 trial

Phase

• Phase 310 trials
• Phase 1/21 trial
• Phase 21 trial

Status

• Completed5 trials
• Recruiting4 trials
• Active, not recruiting3 trials
• Not yet recruiting1 trial
• Suspended1 trial

Lead sponsor

• Novo Nordisk A/S9 trials
• Anji Pharma1 trial
• COUR Pharmaceutical Development Company, Inc.1 trial
• Diasome Pharmaceuticals1 trial
• DreaMed Diabetes1 trial
• and 1 more

Running trials

• Not yet recruiting

  A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity

  NCT07919405· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  NCT07668414· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

  NCT07817251· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

  NCT07599982· DreaMed Diabetes· Source

  Contact: Thomas Blevins, MD

• Active, not recruiting

  GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

  NCT07228117· Medtronic MiniMed, Inc.· Source

• Active, not recruiting

  A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

  NCT07076199· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  NCT06783309· Phase 1/2· COUR Pharmaceutical Development Company, Inc.· Source

  Contact: Emmanuel Lopez

• Active, not recruiting

  A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

  NCT05726227· Phase 3· Novo Nordisk A/S· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Type 1 diabetes2 recruiting
• Type 2 diabetes2 recruiting
• High blood pressure1 recruiting

Closed trials

• Completed

  Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

  NCT06238778· Phase 2· Diasome Pharmaceuticals· Source

• Completed

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

  NCT05259033· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

  NCT03914326· Phase 3· Novo Nordisk A/S· Source